ArticleHuman vaccines & immunotherapeutics2017

Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines.

Qianqian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.